The groundbreaking treatment of tirzepatide peptide represents a major advance in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide696741.bloguetechno.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-78799988